Johannes Möller

Dr. Johannes Möller

Institute of Bioprocess and Biosystems Engineering, Hamburg University of Technology, 21073 Hamburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2019 in Bioprocess and Biosystems Engineering
Verified
Journal Article
Closed access
PDF file
Johannes MöllerJohannes Möller
Johannes Möller
KKKim B Kuchemüller
Kim B Kuchemüller
TSTobias Steinmetz
Tobias Steinmetz
KKKirsten S Koopmann
Kirsten S Koopmann
Ralf PoertnerRalf Poertner
Ralf Poertner

2 March 2021 in Processes
Verified
Journal Article
Open access
PDF file
Johannes MöllerJohannes Möller
Johannes Möller
Ralf PoertnerRalf Poertner
Ralf Poertner
Techniques to provide in vitro tissue culture have undergone significant changes during the last decades, and current applications involve interactions of cells and organoids, three-dimensional cell co-cultures, and organ/body-on-chip tools. Efficient computer-aided and mathematical model-based methods are required for efficient and knowledge-driven characterization, optimization, and routine manufacturing of tissue culture systems. As an alternative to purely experimental-driven research, the usage of comprehensive mathematical models as a virtual in silico representation of the tissue culture, namely a digital twin, can be advantageous. Digital twins include the mechanistic of the biological system in the form of diverse mathematical models, which describe the interaction between tissue culture techniques and cell growth, metabolism, and the quality of the tissue. In this review, current concepts, expectations, and the state of the art of digital twins for tissue culture concepts will be highlighted. In general, DT’s can be applied along the full process chain and along the product life cycle. Due to the complexity, the focus of this review will be especially on the design, characterization, and operation of the tissue culture techniques.

29 November 2022 in Biotechnology Journal
Verified
Journal Article
Open access
Benjamin BayerBenjamin Bayer
Benjamin Bayer
Mark DuerkopMark Duerkop
Mark Duerkop
Ralf PoertnerRalf Poertner
Ralf Poertner
Johannes MöllerJohannes Möller
Johannes Möller
Despite the advantages of mathematical bioprocess modeling, successful model implementation already starts with experimental planning and accordingly can fail at this early stage. For this study, two different modeling approaches (mechanistic and hybrid) based on a four‐dimensional antibody‐producing CHO fed‐batch process are compared. Overall, 33 experiments are performed in the fractional factorial four‐dimensional design space and separated into four different complex data partitions subsequently used for model comparison and evaluation. The mechanistic model demonstrates the advantage of prior knowledge (i.e., known equations) to get informative value relatively independently of the utilized data partition. The hybrid approach displayes a higher data dependency but simultaneously yielded a higher accuracy on all data partitions. Furthermore, our results demonstrate that independent of the chosen modeling framework, a smart selection of only four initial experiments can already yield a very good representation of a full design space independent of the chosen modeling structure. Academic and industry researchers are recommended to pay more attention to experimental planning to maximize the process understanding obtained from mathematical modeling.

24 July 2019 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
PDF file
Johannes MöllerJohannes Möller
Johannes Möller
KBKrathika Bhat
Krathika Bhat
KRKristoffer Riecken
Kristoffer Riecken
Ralf PoertnerRalf Poertner
Ralf Poertner
AZAn‐Ping Zeng
An‐Ping Zeng
UJUwe Jandt
Uwe Jandt
The influence of process strategies on the dynamics of cell population heterogeneities in mammalian cell culture is still not well understood. We recently found that the progression of cells through the cell cycle causes metabolic regulations with variable productivities in antibody‐producing Chimese hamster ovary (CHO) cells. On the other hand, it is so far unknown how bulk cultivation conditions, for example, variable nutrient concentrations depending on process strategies, can influence cell cycle‐derived population dynamics. In this study, process‐induced cell cycle synchronization was assessed in repeated‐batch and fed‐batch cultures. An automated flow cytometry set‐up was developed to measure the cell cycle distribution online, using antibody‐producing CHO DP‐12 cells transduced with the cell cycle‐specific fluorescent ubiquitination‐based cell cycle indicator (FUCCI) system. On the basis of the population‐resolved model, feeding‐induced partial self‐synchronization was predicted and the results were evaluated experimentally. In the repeated‐batch culture, stable cell cycle oscillations were confirmed with an oscillating G1 phase distribution between 41% and 72%. Furthermore, oscillations of the cell cycle distribution were simulated and determined in a (bolus) fed‐batch process with up to cells/ml. The cell cycle synchronization arose with pulse feeding only and ceased with continuous feeding. Both simulated and observed oscillations occurred at higher frequencies than those observable based on regular (e.g., daily) sample analysis, thus demonstrating the need for high‐frequency online cell cycle analysis. In summary, we showed how experimental methods combined with simulations enable the improved assessment of the effects of process strategies on the dynamics of cell cycle‐dependent population heterogeneities. This provides a novel approach to understand cell cycle regulations, control cell population dynamics, avoid inadvertently induced oscillations of cell cycle distributions and thus to improve process stability and efficiency.

23 October 2018 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
Johannes MöllerJohannes Möller
Johannes Möller
KKKatrin Korte
Katrin Korte
RPRalf Pörtner
Ralf Pörtner
AZAn‐Ping Zeng
An‐Ping Zeng
UJUwe Jandt
Uwe Jandt

13 January 2021 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
LALukas Arndt
Lukas Arndt
VWVincent Wiegmann
Vincent Wiegmann
KKKim B. Kuchemüller
Kim B. Kuchemüller
FBFrank Baganz
Frank Baganz
Ralf PoertnerRalf Poertner
Ralf Poertner
Johannes MöllerJohannes Möller
Johannes Möller
Miniaturized bioreactor (MBR) systems are routinely used in the development of mammalian cell culture processes. However, scale‐up of process strategies obtained in MBR‐ to larger scale is challenging due to mainly non‐holistic scale‐up approaches. In this study, a model‐based workflow is introduced to quantify differences in the process dynamics between bioreactor scales and thus enable a more knowledge‐driven scale‐up. The workflow is applied to two case studies with antibody‐producing Chinese hamster ovary cell lines. With the workflow, model parameter distributions are estimated first under consideration of experimental variability for different scales. Second, the obtained individual model parameter distributions are tested for statistical differences. In case of significant differences, model parametric distributions are transferred between the scales. In case study I, a fed‐batch process in a microtiter plate (4 ml working volume) and lab‐scale bioreactor (3750 ml working volume) was mathematically modeled and evaluated. No significant differences were identified for model parameter distributions reflecting process dynamics. Therefore, the microtiter plate can be applied as scale‐down tool for the lab‐scale bioreactor. In case study II, a fed‐batch process in a 24‐Deep‐Well‐Plate (2 ml working volume) and shake flask (40 ml working volume) with two feed media was investigated. Model parameter distributions showed significant differences. Thus, process strategies were mathematically transferred, and model predictions were simulated for a new shake flask culture setup and confirmed in validation experiments. Overall, the workflow enables a knowledge‐driven evaluation of scale‐up for a more efficient bioprocess design and optimization.